The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · North America

[2026 update] US compounding rules and how they changed

Solved
Solved by k.haddad in post #5
Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use. I looked this up rather than remembered it, which is the right order.

Jump to the accepted answer →

FW
f.weissTL214 Feb 2025#1

US compounding rules and how they changed Writing it up because I had to work it out twice and would rather nobody else did.

Regional question, dated January 2026, because everything in this category expires.

The position differs between the jurisdictions people usually treat as one, and the differences are not marginal. I have set out what I can verify for my own region from primary sources rather than summaries.

If you can confirm or contradict this for yours, please date the answer.

10 likes 17mo
TT
taper_tableTL3Regular27 Feb 2025#2

Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction.

That holds under the stated conditions and I have stated them.

0 likes 17mo
AH
a.hartmannTL28 Mar 2025 · edited#3

Noted, and thank you for writing it out rather than summarising it.

28 likes 17mo
EC
excursion_checkTL3Regular16 Mar 2025#4
taper_table, post #2: Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction. That holds under the stated conditions and I have stated them. Go to post

Both are useful and different. The account tells you what happens in practice; the criterion tells you what to write.

The honest answer is that it depends, and here is what it depends on.

14 likes in reply to #2 16mo
KH
k.haddadTL2 Solution24 Mar 2025#5

Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use.

I looked this up rather than remembered it, which is the right order.

7 likes 16mo
BM
buffer_marginTL3Regular31 Mar 2025#6

Shortage status determines what compounding is permitted in some jurisdictions, which is why the availability question and the compounding question are linked.

If it helps: the failure mode here is usually boring rather than dramatic.

0 likes 16mo
TA
t.abubakarTL27 Apr 2025#7

Coming back to post #5, because the follow-up matters more than the original answer.

Formulary position changes on a schedule that is published in advance, which means a decision made now may be answering last year's formulary.

5 likes 16mo
P
PSkarbekTL313 Apr 2025#8
CS
c.serranoTL220 Apr 2025#9
TN
t.nardoneTL3Regular26 Apr 2025#10

Sensible. I would want the same detail before I acted on it either.

15 likes 15mo
LA
l.aaltonenTL3Regular2 May 2025#11
t.nardone, post #10: Sensible. I would want the same detail before I acted on it either. Go to post

Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end.

27 likes in reply to #10 15mo
DN
d.ndiayeTL28 May 2025#12

Appeals succeed more often than people expect when they answer the stated criterion point by point and include nothing else.

0 likes 15mo
W
WickramasingheTL2Member14 May 2025#13

That is clearer than the version I had in my head. Thank you.

5 likes 14mo
MD
m.dumitruTL219 May 2025#14

Prior authorisation criteria are usually published by the payer and reading them before the appointment changes the outcome more than anything else does.

Two people can read the same figure differently here and both be reasonable.

13 likes 14mo
Z
ZieglerTL3Regular25 May 2025#15
f.weiss, post #1: US compounding rules and how they changed Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated January 2026, because everything in this category expires. The position differs between the jurisdictions people usually treat as one, and the differences are not marginal. I have set out… Go to post

The public assessment documents published at approval are free, detailed and largely unread here.

20 likes in reply to #1 14mo
BJ
b.jansenTL230 May 2025#16

Worth separating two things that post #12 runs together.

Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable.

I would treat that as a working assumption and revisit it.

0 likes 14mo
BP
baseline_peakTL2Member5 Jun 2025#17

Say which country and which state or province. Regulatory position, availability and practical route can all differ within the same continent and frequently do.

2 likes 14mo
BN
b.nwosuTL210 Jun 2025#18

That matches what I have seen, for whatever a single anecdote is worth.

9 likes 14mo
C
CFairweatherTL1Member15 Jun 2025#19
Wickramasinghe, post #13: That is clearer than the version I had in my head. Thank you. Go to post

Appreciated. The plain phrasing does more work here than a longer post would.

14 likes in reply to #13 13mo
SD
s.demirTL220 Jun 2025 · edited#20
b.nwosu, post #18: That matches what I have seen, for whatever a single anecdote is worth. Go to post

On post #16 — agreed on the reasoning, with one qualification.

Compounded preparations and authorised products are different regulatory categories with different oversight, and conflating them produces most of the confusion here.

If anyone can point at the primary source I would be grateful.

29 likes in reply to #18 13mo
ON
o.nybergTL226 Jun 2025#21
taper_table, post #2: Cross-border purchasing raises both a legal question and a practical one, and the legal one is yours to establish for your own jurisdiction. That holds under the stated conditions and I have stated them. Go to post

Where a compounding pathway existed and closed, posts describing it stay in the archive and should be read with their date attached.

That is the version I would defend. It is not the version I started with.

23 likes in reply to #2 13mo
DW
diluent_watchTL2Member1 Jul 2025#22

Cost comparisons should state whether they include the device and the dispensing fee, because those differ between routes and between states.

I have deliberately not rounded that, because the rounding is where the argument starts.

10 likes 13mo
GV
g.verhoevenTL26 Jul 2025#23

I read post #21 twice before replying, because I had assumed the opposite.

Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current.

3 likes 13mo
Z
ZieglerTL3Regular11 Jul 2025 · edited#24

This follows post #21 rather than contradicting it.

The denial letter is the specification for the appeal. It states a criterion and the job is to demonstrate that criterion in the letter's own language.

0 likes 13mo
AP
ar.petrovTL216 Jul 2025#25
g.verhoeven, post #23: I read post #21 twice before replying, because I had assumed the opposite. Date every claim in this subcategory. Positions here have moved repeatedly and old posts are read as current. Go to post

Pharmacy practice varies between pharmacies within the same city, so two honest accounts can be entirely different.

16 likes in reply to #23 12mo
RS
r.scholtenTL2Member21 Jul 2025#26

Where a manufacturer runs a direct supply route, that is a commercial arrangement rather than a regulatory change, and it can end.

I would put this at better than even and not much better.

6 likes 12mo
LA
l.aguirreTL225 Jul 2025#27

The denial letter is the specification for the appeal. It states a criterion and the job is to demonstrate that criterion in the letter's own language.

Old habit: I write down the expected answer before I calculate it.

1 like 12mo
FF
f.fenwickTL3Regular30 Jul 2025#28
k.haddad, post #5: Anyone reporting an outcome should give the stated reason rather than the verdict. The reason is the part somebody else can use. I looked this up rather than remembered it, which is the right order. Go to post

Following this. I have the same question and no better information than the first post.

0 likes in reply to #5 12mo
OV
o.vogelTL24 Aug 2025#29

Worth separating two things that post #25 runs together.

Emotional language in an appeal does not help, however justified it is. The reviewer is checking criteria and the job is to make them checkable.

0 likes 12mo
MD
m.duarteTL29 Aug 2025#30
b.nwosu, post #18: That matches what I have seen, for whatever a single anecdote is worth. Go to post

Understood. Thank you for being specific about the limits of it.

22 likes in reply to #18 12mo